Presenilin expression during induced differentiation of the human neuroblastoma SH-SY5Y cell line.
Human neuroblastoma SH-SY5Y cells stably transfected with both wild-type and exon-9 deleted (deltaE9) presenilin constructs were used to study the role of the presenilin proteins during differentiation. Cells transfected with either wild-type or deltaE9 PS1, of which the latter abolishes normal endoproteolytic cleavage of the protein, showed no obvious differences in their ability to differentiate to a neuronal-like phenotype upon treatment with retinoic acid (RA). A defined pattern of PS1 expression was observed during differentiation with both RA and the phorbol ester TPA. Full-length PS1 was shown to increase dramatically within 5-24 h of RA treatment. TPA gave an earlier and longer lasting increase in full-length PS1 levels. The intracellular distribution pattern of PS1 was markedly altered following RA treatment. Within 24h PS1 was highly up-regulated throughout the cell body around the nucleus. Between 2 and 4 weeks PS1 staining appeared punctate and also localised to the nucleus. Increases in PS1 expression upon treatment with RA and TPA were blocked by treatment with cycloheximide, indicating a role of de-novo protein synthesis in this effect. PS2 expression remained unchanged during differentiation. Levels of full-length PS1 were also seen to increase during neurogenesis and neuronal differentiation in the forebrain of first trimester human foetuses between 6.5 and 11 weeks. These combined observations support the idea that PS1 is involved in neuronal differentiation by a mechanism likely independent of endoproteolysis of the protein.
Flood
Fiona
F
Neurotec Department, Division of Experimental Geriatrics, Karolinska Institutet, KASPAC, Novum pl 5, S-141 86 Huddinge, Sweden.
Sundström
Erik
E
Samuelsson
Eva-Britt
EB
Wiehager
Birgitta
B
Seiger
Ake
A
Johnston
Janet A
JA
Cowburn
Richard F
RF
D001932:Brain Neoplasms / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D005091:Exons; D005333:Fetus / Q000166:cytology; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008565:Membrane Proteins / Q000096:biosynthesis* / Q000235:genetics; D009154:Mutation / Q000235:genetics; D009447:Neuroblastoma / Q000378:metabolism* / Q000473:pathology; D053764:Presenilin-1; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014162:Transfection; D014212:Tretinoin / Q000633:toxicity
D008565:Membrane Proteins; C508853:PSEN1 protein, human; D053764:Presenilin-1; D014212:Tretinoin; D013755:Tetradecanoylphorbol Acetate